MRK

Merck & Company, Inc. MRK

$127.50 -0.13 (-0.10%)

Neutral · +0.96σ

+ Compare Open in Sniper

Mkt cap $298.3B

P/E 35.9

Day $127.03 – $131.74

52wk $106.03 – $131.74

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Merck & Company, Inc. is a healthcare company listed in the US.

MRK last traded at $127.50, down 0.1% on the day; that's in the upper part of its 52-week range ($106.03–$131.74). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 58), the trend is quiet (ADX 17), and volume is about normal (1.2×). On the business side, revenue is growing 5% year over year and the business keeps about 22 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI

0–100 · <30 oversold

Trend strength · ADX

>25 = strong trend

Volume vs avg

1.18×

1× = average

Stretch from avg

+1.0 ATR

− below · + above

Zone touches

tests of this zone

Suggested hold

3–30

bars (≈ days)

Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth

+4.9%

year over year

Free-cash-flow margin

21.6%

cash kept per $ of sales

Debt / equity

1.07

lower = less leveraged

P/E ratio

35.9

price ÷ yearly profit

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $81.70 (fair range $64–$126); today's price sits 56% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$81.70

Fair-value range

$63.90 – $125.83

Margin of safety

-56%

Verdict

Overvalued

Accounting quality Weak

✓ Positive retained earnings
✓ Gross margin 77% (pricing power)

⚠ Debt exceeds cash
⚠ Quick ratio 0.62 (fragile)
⚠ Receivables growing faster than revenue
⚠ Inventory growing faster than revenue

Price implies ~11% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

MRK is a $298.3 billion company, priced at 36× last year's earnings.

Mkt cap $298.3B

P/E ttm 35.9

Fwd P/E —

Beta —

Day range $127.03 – $131.74

52w range $106.03 – $131.74

Avg vol —

RSI(2) 81.5

ROE —

Net mgn —

FCF mgn 21.6%

Debt/Eq 1.07

Div yld —

Sector Healthcare

Industry Drug Manufacturers - General

Next earn —

52-week range · today's price

$106.03$131.74